Effect of dietary carbohydrate restriction with and without weight loss on atherogenic dyslipidemia.
Increasing evidence suggests a role for carbohydrate restriction in the dietary treatment of atherogenic dyslipidemia. The effects of carbohydrate restriction on the specific aspects of lipoprotein metabolism affected by atherogenic dyslipidemia under weight-stable and weight-loss conditions are reviewed here.
Wood
Richard J
RJ
Department of Nutritional Sciences, University of Connecticut, Storrs, Connecticut, USA. woodr@dom.pitt.edu
D050197:Atherosclerosis / Q000209:etiology; D002784:Cholesterol / Q000378:metabolism; D008076:Cholesterol, HDL / Q000378:metabolism; D008078:Cholesterol, LDL / Q000378:metabolism; D050528:Diet, Carbohydrate-Restricted; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D006801:Humans; D006949:Hyperlipidemias / Q000178:diet therapy*; D050356:Lipid Metabolism / Q000187:drug effects*; D008074:Lipoproteins / Q000378:metabolism*; D014280:Triglycerides / Q000378:metabolism; D015431:Weight Loss / Q000502:physiology*
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D004040:Dietary Carbohydrates; D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol